Intravascular coagulation. 2. Underlying conditions and therapy.

Therapy for intravascular coagulation is directed primarily against the underlying disorder. If the latter is not readily correctable or if the patient is bleeding actively, anticoagulation with intermittent administration of heparin by the intravenous route is indicated. If thrombocytopenia is present, heparinization must be accompanied by platelet transfusion. The efficacy of therapy is judged by the cessation of bleeding or thrombosis, improvement of organic dysfunction, and correction of the levels of the coagulation factors, particularly factor V and fibrinogen.

[1]  V. P. Butler,et al.  The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity. , 1976, The Journal of clinical investigation.

[2]  R. B. Babcock,et al.  Heparin-induced immune thrombocytopenia. , 1976, The New England journal of medicine.

[3]  P. Flute,et al.  Fibrinogen Metabolism in Acute Hepatitis and Active Chronic Hepatitis , 1975, British journal of haematology.

[4]  H. Gralnick,et al.  ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIA , 1975, British journal of haematology.

[5]  H. Gralnick,et al.  Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. , 1975, Blood.

[6]  R. Rosenberg Actions and interactions of antithrombin and heparin. , 1975, The New England journal of medicine.

[7]  P. Damus,et al.  Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy. , 1975, Thrombosis research.

[8]  H. Gralnick,et al.  Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis. , 1974, Human pathology.

[9]  Bowie Ej,et al.  Symposium on the diagnosis and treatment of intravascular coagulation-fibrinolysis (ICF) syndrome, with special emphasis on this syndrome in patients with cancer. Introduction. , 1974 .

[10]  T. Kurze,et al.  Defibrination after brain-tissue destruction: A serious complication of head injury. , 1974, The New England journal of medicine.

[11]  L. Harker,et al.  HEMOSTASIS IN MALIGNANCY * † , 1974, Annals of the New York Academy of Sciences.

[12]  H. Gralnick,et al.  Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. , 1972, Blood.

[13]  V. Marder,et al.  Comparative Effects of Fibrinogen Degradation Fragments D and E on Coagulation , 1972, British journal of haematology.

[14]  R. Colman,et al.  Disseminated intravascular coagulation (DIC): an approach. , 1972, The American journal of medicine.

[15]  R. Williams,et al.  Intravascular coagulation in acute hepatic necrosis. , 1970, American heart journal.

[16]  V. Gurewich,et al.  Detection of intravascular coagulation by a serial-dilution protamine sulfate test. , 1971, Annals of internal medicine.

[17]  H. Gralnick,et al.  Thrombosis with epsilon aminocaproic acid therapy. , 1971, American journal of clinical pathology.

[18]  J. Vreeken,et al.  Arterial aneurysm as a cause of consumption coagulopathy. , 1971, The New England journal of medicine.

[19]  T. Yoshikawa,et al.  INFECTION AND DISSEMINATED INTRAVASCULAR COAGULATION , 1971, Medicine.

[20]  P. Straub,et al.  Reptilase®‐R—A New Reagent in Blood Coagulation , 1971, British journal of haematology.

[21]  D. Deykin Warfarin therapy. 2. , 1970, The New England journal of medicine.

[22]  G. Pineo,et al.  Microangiopathic Haemolytic Anaemia and Mucin‐forming Adenocarcinoma , 1970, British journal of haematology.

[23]  R. Colman,et al.  Coagulation Studies in the Hyperacute and Other Forms of Renal-Allograft Rejection , 1969 .

[24]  C. Grushkin,et al.  HEPARIN THERAPY IN THE HÆMOLYTIC-URÆMIC SYNDROME , 1969 .

[25]  S. Inceman,et al.  Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia. , 1969, The American journal of medicine.

[26]  D. Purtilo,et al.  Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. , 1969, The New England journal of medicine.

[27]  F. Breen,et al.  Ethanol gelation: a rapid screening test for intravascular coagulation. , 1968, Annals of internal medicine.

[28]  R. Colman,et al.  Chronic intravascular coagulation syndrome. , 1968, The New England journal of medicine.

[29]  R. Lerner,et al.  Shwartzman reaction after human renal homotransplantation. , 1968, The New England journal of medicine.

[30]  D. Tatter,et al.  PSEUDOMONAS SEPTICEMIA WITH INTRAVASCULAR CLOTTING LEADING TO THE GENERALIZED SHWARTZMAN REACTION. , 1964, The New England journal of medicine.

[31]  J. Peden,et al.  Use of the plasma thrombin time to assess the adequacy of in vivo neutralization of heparin: comparative studies following operations employing extracorporeal circulation. , 1959, Blood.

[32]  C. Schneider ETIOLOGY OF FIBRINOPENIA: FIBRINATION DEFIBRINATION * , 1959, Annals of the New York Academy of Sciences.